儿童二尖瓣修复中人工腱索的耐久性与延长:综合超声心动图分析
中位随访4.0年,发现人工腱索随时间进行性延长,且与左心室容积相关,提示与心室生长耦联;瓣膜梯度稳定,无腱索限制、断裂或钙化。10年累积中度以上二尖瓣反流发生率为45.5%,再手术率为20.1%,再脱垂伴中度以上反流为12.1%。
要点
- ePTFE人工腱索在儿童二尖瓣修复中耐久性良好,无断裂或钙化。
- 人工腱索随时间延长并与左心室容积相关,适应心室生长。
- 10年累积中度以上反流45.5%、再手术20.1%、再脱垂12.1%。
核心结论
- 儿童二尖瓣修复中ePTFE人工腱索耐久性优异,可随左心室重构适应性延长,不引起瓣膜限制。
研究设计与样本
- 中位手术年龄5岁(IQR 2-12岁),中位随访4.0年(95%CI 2.5-7.0年),中位人工腱索数量4条(IQR 2-6条)。
主要发现
- 舒张期人工腱索中位长度从出院时1.78 cm(IQR 1.38-2.07 cm)增至10年时2.28 cm(IQR 1.88-2.70 cm)。
- 收缩期人工腱索中位长度从1.40 cm(IQR 1.10-1.58 cm)增至2.10 cm(IQR 1.60-2.50 cm)。
- 人工腱索延长与左心室舒张末期容积(P = .002)和收缩末期容积(P = .018)相关。
- 二尖瓣跨瓣梯度保持稳定,人工腱索长度与对合长度减少或膨隆高度增加无关联。
- 无人工腱索断裂或钙化发生。
关键数值与推荐
- 10年累积中度或以上二尖瓣反流发生率为45.5%(95%CI 30.5%-68.0%)。
- 10年累积再手术率为20.1%(95%CI 10.8%-37.4%)。
- 10年累积再脱垂伴中度或以上二尖瓣反流发生率为12.1%(95%CI 5.3%-27.6%)。
临床怎么用
- 儿童二尖瓣修复使用ePTFE人工腱索长期安全,可随心室生长适应性延长。
- 术后需长期超声随访监测反流与再手术风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the long-term remodeling, biological adaptation, and clinical outcomes of expanded polytetrafluoroethylene (ePTFE) artificial chords (AC) used for pediatric mitral valve (MV) repair through comprehensive echocardiographic analysis. METHODS: We retrospectively reviewed all patients younger than age 18 years undergoing MV repair with ePTFE AC between 2005 and 2024. Serial echocardiographic measurements included AC length, MV coaptation geometry, regurgitation severity and stenosis, and left ventricular (LV) volumes. RESULTS: Forty-two patients (median operative age, 5 years; interquartile range [IQR], 2-12 years) underwent MV with AC. Median follow-up was 4.0 years (95% CI, 2.5-7.0 years). Median AC number was 4 (IQR, 2-6). Progressive AC elongation was observed over time, with median diastolic AC length from 1.78 cm (IQR, 1.38-2.07 cm) at discharge to 2.28 cm (IQR, 1.88-2.70 cm) at 10 years, and median systolic length from 1.40 cm (IQR, 1.10-1.58 cm) to 2.10 cm (IQR, 1.60-2.50 cm). AC elongation correlated with LV volumes (end-diastolic and end-systolic, P = .002 and P = .018, respectively), suggesting coupling with ventricular growth. Transmitral gradients remained stable and no association between AC length and reduced coaptation length or increased tenting height were observed, supporting absence of leaflet restriction. No AC rupture or calcification occurred. At 10 years, cumulative incidence of moderate or greater MR was 45.5% (95% CI, 30.5%-68.0%), reoperation was 20.1% (95% CI, 10.8%-37.4%), and reprolapse with moderate or greater MR was 12.1% (95% CI, 5.3%-27.6%). CONCLUSIONS: In pediatric MV repair, ePTFE-AC demonstrated excellent durability and adaptative elongation alongside LV remodeling, without inducing valve restriction. These findings support long-term safety of AC-based repair and highlight ventricular-valvular remodeling in growing hearts.
引用
- Fournier E, Deng MX, Provost B, et al. Durability and elongation of artificial chords in pediatric mitral valve repair: A comprehensive echocardiographic analysis. J Thorac Cardiovasc Surg. 2026. PMID: 42309391. doi:10.1016/j.jtcvs.2026.06.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。